How important is cervical cancer screening in women during pregnancy?

Share This Post

1. The importance of cervical cancer screening in women during pregnancy

Juvenile laryngeal papilloma is more common in children and adolescents, mainly pregnant women with low-risk HPV infection in the reproductive tract during pregnancy, which is caused by mother-to-child transmission to infants during delivery through the birth canal, mainly HPV infections type 6 and 11. Children with juvenile laryngeal papilloma may have no clinical symptoms in the early stage. As the laryngeal papilloma increases, respiratory symptoms appear. If the lesion is extensive, it may cause severe breathing difficulties and death. Screening of cervical cancer in pregnant women to prevent HPV infection can effectively prevent the virus from being transmitted to babies through childbirth. The birth of a healthy baby will undoubtedly contribute to individuals, families and society.

2. Methods of screening for cervical cancer in women during pregnancy. Routine high-risk HPV typing and liquid-based cytology tests are performed on women before pregnancy.

If the test result is positive, colposcopy is recommended. Colposcopy found a suspicious lesion and gave a cervical biopsy. If cervical cancer or precancerous lesions are found, wait for the cervical lesions to heal before considering fertility.

3. HPV infection in pregnant women. Pregnant women detect low-risk HPV infections in the reproductive tract before and after pregnancy, especially HPV types 6 and 11. The pregnant woman should be delivered by caesarean section to minimize the incidence of juvenile laryngeal papilloma.

Cervical cancer screening for pregnant women or women of appropriate age is particularly important, because this group of people bears the happiness of two or even three generations. Since the birth of a healthy baby, since human intervention can be used for disease prevention, medicine has developed so progressively. Medical technology can benefit people and prevent diseases before they happen. So, dear female compatriots, what are you waiting for? Hurry up and join the cervical cancer screening team.

Website |  + posts

Susan Hau is a distinguished researcher in the field of cancer cell therapy, with a particular focus on T cell-based approaches and cancer vaccines. Her work spans several innovative treatment modalities, including CAR T-cell therapy, TIL (Tumor-Infiltrating Lymphocyte) therapy, and NK (Natural Killer) cell therapy.

Hau's expertise lies in cancer cell biology, where she has made significant contributions to understanding the complex interactions between immune cells and tumors.

Her research aims to enhance the efficacy of immunotherapies by manipulating the tumor microenvironment and exploring novel ways to activate and direct immune responses against cancer cells.

Throughout her career, Hau has collaborated with leading professors and researchers in the field of cancer treatment, both in the United States and China.

These international experiences have broadened her perspective and contributed to her innovative approach to cancer therapy development.

Hau's work is particularly focused on addressing the challenges of treating advanced and metastatic cancers. She has been involved in clinical trials evaluating the safety and efficacy of various immunotherapy approaches, including the promising Gamma Delta T cell therapy.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Gene Therapy for Gaucher’s Disease in China
AI & Technology

Gene Therapy for Gaucher’s Disease in China

Gene therapy for Gaucher’s disease in China offers a potential cure by correcting the faulty GBA gene. Using viral vectors or CRISPR, this treatment could eliminate lifelong enzyme therapy. Costs range from
300
,
000

300,000–400,000 USD, covering infusion and monitoring. China leads in clinical trials and advanced care. Contact us on WhatsApp +852 6428 1793 to explore treatment options and eligibility today!

Gene Therapy for Wilson's Disease in China
Biotech Innovations

Gene Therapy for Wilson’s Disease in China

Gene therapy for Wilson’s disease in China offers a groundbreaking cure by correcting the faulty ATP7B gene. With advanced viral vector and CRISPR-based treatments, patients can potentially avoid lifelong medications. The cost ranges from
250
,
000
–250,000–300,000 USD, covering therapy and follow-up care. China leads in clinical trials and affordable gene therapies. Contact us on WhatsApp +852 6428 1793 to explore treatment options and eligibility today!

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

CancerFax is the most trusted online platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies.

Send your medical reports and get a free analysis.

🌟 Join us in the fight against cancer! 🌟

Привет,

CancerFax — это самая надежная онлайн-платформа, призванная предоставить людям, столкнувшимся с раком на поздних стадиях, доступ к революционным клеточным методам лечения.

Отправьте свои медицинские заключения и получите бесплатный анализ.

🌟 Присоединяйтесь к нам в борьбе с раком! 🌟